Reckitt Benckiser Group (LON:RB) Given a GBX 8,300 Price Target by UBS Group Analysts

UBS Group set a GBX 8,300 ($108.44) price target on Reckitt Benckiser Group (LON:RB) in a report issued on Monday, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

RB has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft set a GBX 8,200 ($107.13) price objective on Reckitt Benckiser Group and gave the company a buy rating in a research note on Monday. JPMorgan Chase & Co. set a GBX 9,000 ($117.59) price target on shares of Reckitt Benckiser Group and gave the company a buy rating in a research note on Monday. Jefferies Financial Group set a GBX 6,050 ($79.04) price objective on shares of Reckitt Benckiser Group and gave the company a neutral rating in a research note on Monday. Berenberg Bank set a GBX 8,500 ($111.05) target price on Reckitt Benckiser Group and gave the stock a buy rating in a research report on Thursday, April 29th. Finally, The Goldman Sachs Group set a GBX 6,400 ($83.62) price target on Reckitt Benckiser Group and gave the stock a neutral rating in a report on Monday. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of Buy and a consensus target price of GBX 7,928.57 ($103.59).

The firm has a market capitalization of £48.36 billion and a PE ratio of 40.79. The stock has a 50-day simple moving average of GBX 6,356.14. The company has a quick ratio of 0.53, a current ratio of 0.77 and a debt-to-equity ratio of 116.01. Reckitt Benckiser Group has a 52-week low of GBX 5,782 ($75.54) and a 52-week high of GBX 8,020 ($104.78).

In other news, insider Olivier Bohuon purchased 500 shares of the stock in a transaction on Tuesday, March 16th. The shares were acquired at an average price of GBX 6,316 ($82.52) per share, for a total transaction of £31,580 ($41,259.47). Also, insider Laxman Narasimhan sold 12,406 shares of Reckitt Benckiser Group stock in a transaction dated Thursday, March 25th. The stock was sold at an average price of GBX 6,453 ($84.31), for a total value of £800,559.18 ($1,045,935.69).

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Further Reading: What is Blockchain?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.